Skip to main content
Premium Trial:

Request an Annual Quote

Structural GenomiX and OSI Pharmaceuticals in Research Collaboration

NEW YORK, Sept. 3 (GenomeWeb News) -- Structural GenomiX of San Diego and OSI Pharmaceuticals of Melville, NY, announced a research collaboration, the companies said today.

 

SGX will apply its SGX gene-to-structure platform to explore OSI drug targets to determine oncology drug candidates. SGX will generate co-crystal data to meter target interaction.

 

SGX will receive undisclosed upfront payments, research funding, and milestone payments, the company said.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.